SCHEMBL22101696

SCHEMBL22101696

CCc1cc(=O)n2cc(C)cc(C)c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 1/20 0.39
MAT2A P31153 1/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PKM P14618 3/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 1/20 0.38
MAPT P10636 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
POLB P06746 2/20 0.37
HTT P42858 1/20 0.36
NOS3 P29474 1/20 0.36
NOS2 P35228 1/20 0.36
RXFP1 Q9HBX9 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22101725 0.84 GRIN1 (0.40) KDM5BMAT2AGRIN1GRIN2AL3MBTL1
SCHEMBL22101695 0.84 MAPT (0.40) KDM5BMAT2AGRIN1GRIN2AL3MBTL1
SCHEMBL22101427 0.84 PABPC1 (0.42) KDM5BMAT2AL3MBTL1PKMKDM4E
SCHEMBL22393765 0.83 MAPT (0.40) KDM5BMAT2AL3MBTL1PKMKDM4E
SCHEMBL13759891 0.77 PIK3CB (0.36) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL13759892 0.77 KDM4E (0.36) L3MBTL1KDM4EALDH1A1MAPTPIK3CD
SCHEMBL13833755 0.76 PKM (0.58) PKMKDM4EALDH1A1MAPTPOLB
SCHEMBL22101440 0.75 POLB (0.33) KDM5BMAT2AL3MBTL1PKMTSHR
SCHEMBL17298042 0.74 GRIN1 (0.62) GRIN1GRIN2APKMKDM4EALDH1A1
SCHEMBL22423478 0.72 HEXA (0.34) KDM4EALDH1A1NOS3NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666772-A1 DIARYLTHIOHYDANTOIN COMPOUND AS ANDROGEN RECEPTOR ANTAGONIST Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2020-06-17 EP disclosed